市场调查报告书
商品编码
1358973
2030 年医疗保健市场人工智慧 (AI) 预测:按产品、技术、用途、最终用户和地区进行的全球分析Artificial Intelligence in Healthcare Market Forecasts to 2030 - Global Analysis By Offering, Technology, Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球人工智慧(AI)医疗保健市场规模将达到224.2亿美元,预测期内年复合成长率为45.6%,预计到2030年将达到3,110.4亿美元。
人工智慧 (AI) 涉及使用演算法和软体来分析复杂的医疗资料。人工智慧被定义为将基于人类智慧的各种功能,如推理、学习和解决问题的能力,应用于生物学、电脑科学、数学、语言学、心理学和工程学等各个领域的智慧系统。人工智慧在领域的应用正在提高医学研发的效率、创造力和成本效益。
根据 2020 年 NCBI 的一项研究,基于人工智慧的演算法在由医疗专业人员诊断为阴性的 25 名患者资料正确识别了 68% 的 COVID-19 阳性病例。
随着製药和医疗技术公司增加人工智慧(AI)支出以发展业务,该行业预计将迅速扩张。普华永道表示,人工智慧 (AI) 有效、快速,并且以显着更低的成本执行营运任务。此外,人工智慧将协助医疗保健专业人员早期发现和诊断所有疾病。因此,该行业的大多数医疗保健提供者都在增加投资。
儘管人工智慧(AI)在医疗保健行业的应用较多,但其普及仍然较低。因为医疗保健提供者必须处理几个复杂的问题。人工智慧的整合可能会引入错误,并造成患者的诊断和所提供的药物之间的脱节。资料隐私问题也是领域领域人工智慧的一个障碍。许多国家都有专门的法律来保护病患的健康资讯。然而,违反这项法规可能会产生财务和法律后果。由于不道德地收集敏感资料等问题,病患资料安全风险也随之增加。因此,对病患安全和不道德资料收集的担忧日益增加,阻碍了整体市场的扩张。
大型复杂资料,也称为巨量资料,包括点击流、网路和社交媒体互动、心电图 (ECG)、X 射线和脉搏血氧计等医疗设备的读数、医疗申请等申请记录,用于医疗保健领域来识别从电子健康记录(EMR)、药物、生物辨识资料等收集的资讯。在过去的年度中,随着医疗保健专业人员采用电子健康记录(EHR)、数位化检查幻灯片和高解析度放射影像,巨量资料收集和分析工具的发展变得更加复杂和广泛。 。
人工智慧是一个复杂的系统,企业需要具有一定技能的人员来设计、管理和部署人工智慧系统。例如,使用人工智慧系统的个人应该熟悉深度学习、认知运算、机器学习和机器智慧等技术。然而,复製人脑行为并将人工智慧解决方案整合到现有系统中是一项艰鉅的任务,需要大量的资料处理。即使很小的错误也会导致系统故障或对预期结果产生负面影响。
在分析期间,COVID-19的影响预计将显着推动医疗保健市场的人工智慧(AI)。 AI 透过监测病毒传播来诊断 COVID-19 的能力显着增加了对基于 AI 的工具和解决方案的需求。此外,对用于分析人群流行病风险评估和捕获即时资料的电子健康记录(EHR)系统的需求不断增长,也促进了市场的扩张。
在预测期内,软体领域占据了最大的市场份额,这主要是由于人工智慧驱动的软体解决方案在医疗机构、医疗保健提供者、消费者和付款人之间的快速普及。软体领域的扩张是由医疗保健产业对基于人工智慧的软体解决方案的使用增加投资所推动的。此外,这种增长与人工智慧和基于机器学习的技术在世界各地各种医疗保健应用中的越来越多的使用有关。
预计製药和生物技术公司部门在预测期内将呈现良好的成长。在医疗保健领域,人工智慧(AI)被用来支援基因序列测定工作以及预测药物的有效性和安全性。该市场领域的扩张是由不同市场参与企业之间不断增加的合作伙伴关係所推动的。例如,默克公司和内华达州杨森製药公司于2020年7月共同开发了人工智慧诊断工具。该技术有助于提高对被忽视的热带疾病 (NTD)、血吸虫病和土源性蠕虫病 (STH) 的检测。
由于 IT 基础设施的快速发展和专门从事人工智慧技术的创业项目,亚太地区预计将在整个外推期内占据最大份额。采用率的推动因素是私人投资者、创业投资和非营利组织为改善治疗结果、资料分析、安全性和降低成本而增加的投资。此外,推动亚太市场成长的主要原因之一是支持和促进医疗机构和医疗服务提供者快速采用基于人工智慧的技术的有利政府政策。
由于对尖端数位技术的需求不断增长,预计北美在预测期内将实现盈利增长。北美拥有强大且发达的医疗保健、IT 和通讯基础设施,因此医疗保健领域的人工智慧 (AI) 市场正在不断扩大。该地区的医疗保健产业也得到鼓励使用尖端数位技术的政府法规的支持。北美拥有庞大的患者群。据估计,超过一半的美国患有一种或多种慢性病。因此,该地区的住院患者人数不断增加。
According to Stratistics MRC, the Global Artificial Intelligence in Healthcare Market is accounted for $20.87 billion in 2023 and is expected to reach $175.00 billion by 2030 growing at a CAGR of 35.5% during the forecast period. Artificial intelligence (AI) is defined as the study of intelligent agents, i.e., any agent or tool that has the ability to comprehend and grasp its environment and, as a result, to determine the appropriate course of action to increase its chances of succeeding. AI also refers to situations in which machines can mimic the learning and problem-solving processes of the human brain.
According to the statistics published by the CI security, data breaches in the healthcare industry increased by around 36.0% in the second half of 2020. This revealed that around 21.3 million patient records were hampered.
Electronic health records, medical equipment, wearable sensors, and genomics are just a few of the sources of the data explosion in the healthcare sector. This flood of data contains a wealth of insights that AI is just beginning to unlock. Moreover, AI algorithms can make predictions, find hidden patterns in this data, and assist healthcare professionals in making decisions that are supported by the best available evidence.
Data security and privacy are of utmost importance in the healthcare industry because of the sensitive patient data that is handled there. Additionally, an increased risk of data breaches, which could potentially harm patients and have legal repercussions, exists as AI systems become more dependent on access to large volumes of patient data. It's difficult to balance providing AI with access to data while maintaining strict data security protocols.
AI facilitates the growth of telemedicine and remote patient monitoring, which have become more popular, particularly during the COVID-19 pandemic. Furthermore, AI-powered virtual healthcare platforms make it possible to manage chronic diseases, monitor symptoms, and conduct remote consultations, ensuring continuity and accessibility of care, especially for people living in rural or remote areas.
Healthcare organizations are attractive targets for cyber attacks as they gather enormous amounts of private patient data. Patient confidentiality may be violated, patient records may be compromised, and identity theft may occur as a result of data breaches and security breaches. However, to lessen these risks, it is essential to maintain strong data security procedures, encryption, and regulatory compliance.
The COVID-19 pandemic has significantly altered healthcare priorities and accelerated the adoption of technology, including artificial intelligence. Increased investments in AI-driven solutions for telemedicine, vaccine development, drug discovery, and pandemic response followed the pandemic's emphasis on the value of effective healthcare delivery, remote monitoring, and quick diagnostics. Moreover, COVID-19 highlighted the potential of AI to improve healthcare resilience, data-driven decision-making, and the development of creative solutions for upcoming healthcare challenges, even though it puts a strain on healthcare resources and supply chains.
During the forecast period, it is anticipated that the services segment will hold the largest share. For the successful integration and operation of healthcare IT systems, such as electronic health records (EHRs), telemedicine platforms, and artificial intelligence applications, a wide range of services, including consulting, implementation, maintenance, and support services, are required. Additionally, services are essential for assisting healthcare providers to make the most of their technology investments, ensure regulatory compliance, and deliver high-quality patient care in an environment where healthcare is becoming more and more digitized.
The artificial intelligence market in healthcare is seeing the highest CAGR in the precision medicine segment. Customizing medical care and interventions for each patient based on genetic make-up, way of life and unique health characteristics is known as precision medicine. The development of personalized treatment plans, advances in genomics, and the growing accessibility of patient-specific data have all contributed to the growing popularity of this strategy. Moreover, precision medicine is a focus for research, investment, and innovation in the healthcare sector because it holds the promise of more effective therapies, diminished side effects, and improved patient outcomes.
The artificial intelligence market in healthcare is anticipated to hold the largest share in the North American region, particularly the United States. Large patient populations, a thriving pharmaceutical industry, significant investments in medical research and technology, and a well-developed healthcare infrastructure are just a few examples of the factors that contribute to this dominance. Additionally, the area has also led the way in implementing healthcare IT solutions, such as telemedicine and electronic health records (EHRs), which has helped it gain market share. The continued advancements and investments in healthcare technology and services will probably maintain this region's prominence.
In the global healthcare market, the Asia-Pacific region is anticipated to hold the highest CAGR. This rapid growth is caused by a number of variables, including rising healthcare costs, an aging population, an increase in the prevalence of chronic diseases, and increased access to healthcare services. Furthermore, the Asia-Pacific region is also heavily investing in healthcare infrastructure, medical technologies, and digital health solutions, making it a hub for market growth and healthcare innovation.
Some of the key players in Artificial Intelligence in Healthcare market include: Micron Technology Inc., Allscripts Healthcare Solutions, Inc., Medtronic, Enlitic Inc., Google Inc., General Vision, Inc., General Electric Company, Intel Corporation, Amazon Web Services Inc., Nuance Communications Inc., DeepMind Technologies Limited, Next IT Corporation, Koninklijke Philips N.V, Johnson & Johnson Services, Inc, Cloudmedx Inc., IBM Corporation, NVIDIA Corporation, Microsoft Corporation, Hewlett Packard Enterprise Company, Siemens Healthcare and Welltok, Inc.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor, is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
In February 2023, General Electric has signed an agreement with Iraq to set up new power plants and expand capacity at existing units in the country. The deal, which was signed between the US conglomerate and Iraq's Ministry of Electricity, also aims to maintain installed power generation and transmission infrastructure, establish new substations to relieve grid congestion and boost the connectivity between the Jordanian and Iraqi power grids, GE said on Thursday.
In January 2023, Amazon Web Services, Inc. announced its Strategic Collaboration Agreement (SCA) with Slalom, LLC to develop vertical solutions and accelerators on AWS for their customers in healthcare, life sciences, financial services, energy, and media and entertainment industries.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.